1. Home
  2. GTY vs IOVA Comparison

GTY vs IOVA Comparison

Compare GTY & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Getty Realty Corporation

GTY

Getty Realty Corporation

HOLD

Current Price

$33.11

Market Cap

2.1B

Sector

Finance

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

N/A

Current Price

$8.15

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GTY
IOVA
Founded
1955
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.7B
IPO Year
1998
2008

Fundamental Metrics

Financial Performance
Metric
GTY
IOVA
Price
$33.11
$8.15
Analyst Decision
Buy
Buy
Analyst Count
5
10
Target Price
$32.60
$9.00
AVG Volume (30 Days)
360.7K
19.4M
Earning Date
04-22-2026
05-07-2026
Dividend Yield
5.92%
N/A
EPS Growth
8.00
14.84
EPS
0.79
N/A
Revenue
$221,727,000.00
N/A
Revenue This Year
$9.39
$47.74
Revenue Next Year
$7.83
$40.31
P/E Ratio
$42.44
N/A
Revenue Growth
9.02
N/A
52 Week Low
$25.39
$1.76
52 Week High
$36.83
$9.36

Technical Indicators

Market Signals
Indicator
GTY
IOVA
Relative Strength Index (RSI) 46.35 71.59
Support Level $32.12 $3.57
Resistance Level $33.99 N/A
Average True Range (ATR) 0.57 0.63
MACD 0.06 0.16
Stochastic Oscillator 78.29 76.72

Price Performance

Historical Comparison
GTY
IOVA

About GTY Getty Realty Corporation

Getty Realty Corp is a net lease real estate investment trust in the U.S.A, specializing in the acquisition, financing, and development of convenience, automotive, and other single-tenant retail real estate. The company's portfolio includes convenience stores, express tunnel car washes, automotive service centers (gasoline and repair, oil and maintenance, tire and battery, and collision), drive-thru quick service restaurants, and certain other freestanding retail properties. It generates maximum revenue in the form of rental income.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: